Self-Medication With Cannabis Linked to Anxiety, Depression, Paranoia
THURSDAY, Sept. 4, 2025 -- Initiating cannabis use for self-medication is associated with higher weekly use and increased anxiety, depression, and paranoia, according to a study published online Aug. 26 in BMJ Mental Health.
Edoardo Spinazzola, M.D., from King's College London, and colleagues examined reasons for first using cannabis (RFUCs) and their associations with reasons for continuing cannabis use, weekly consumption, and symptoms of paranoia, anxiety, and depressive symptoms using data from the Cannabis&Me survey, including 2,573 current and 816 past cannabis users aged 18 years or older.
The mean weekly consumption was 206 delta-9-tetrahydrocannabinol (THC) units. The researchers found that weekly THC units were higher with initiation of cannabis for anxiety, for depression, or because family members were using it. Higher paranoia scores were seen in association with RFUC to relieve physical discomfort, anxiety, depression, and minor psychotic symptoms. Associations for anxiety and depression were similar. In contrast, lower paranoia and anxiety were seen for starting for fun or curiosity. Increased depression was seen in association with RFUC for boredom.
"This research suggests that using cannabis as a [means] to self-medicate physical or mental discomfort can have a negative impact on the levels of paranoia, anxiety, and depression," Spinazzola said in a statement. "Most of these subgroups had average scores of depression and anxiety which were above the threshold for referral to counselling."
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Drop in Hospital Salaries, Staffing Reported After Private Equity Acquisitions
FRIDAY, Sept. 26, 2025 -- U.S. hospitals that undergo private equity acquisition may reduce salaries and staffing after acquisition, especially in emergency departments (EDs) and...
Poor Mental Health Outcomes More Likely With Hyperemesis Gravidarum
FRIDAY, Sept. 26, 2025 -- Hyperemesis gravidarum is associated with an increased risk for poorer mental health outcomes compared with pregnancy without hyperemesis gravidarum...
Young Adult Cancer Survivors Face Higher Social Risks
FRIDAY, Sept. 26, 2025 -- Young adult cancer survivors face elevated social risks, according to a study presented at the 18th AACR Conference on the Science of Cancer Health...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.